Pacific Biosciences of California, Inc. / Fundamentals
Income statement
- Net revenue
€133.15M - Cost of goods sold
€104.69M - Gross profit
€28.47M - SG&A expenses
€137.95M - R&D expenses
€89.19M - EBITDA
-€393.79M - D&A
€26.98M - EBIT
-€562.02M - Interest expenses
€8.33M - EBT
-€448.92M - Tax expenses
€41.79K - Net income
-€448.96M
Cash flow statement
- Net deferred tax
-€640.57K - Non-cash items
-€55.36M - Changes in working capital
€28.82M - Operating cash flow
-€127.56M - Capex
€2.36M - Other investing cash flow
-€4.26M - Net investing cash flow
€129.50M - Total cash dividends paid
€0.00 - Issuance of common stock
€157.80K - Debt repayment
€0.00 - Other financing cash flow
-€40.45M - Net financing cash flow
-€40.45M - Foreign exchange effects
€0.00 - Net change in cash
-€40.67M - Cash at end of period
€48.31M - Free cash flow
-€125.19M
Balance sheet
- Cash and cash equivalents
€46.74M - Cash and short-term investments
€268.45M - Total receivables
€27.51M - Inventory
€45.92M - Other current assets
€10.72M - Total current assets
€352.61M - Property, plant & equipment
€56.81M - Goodwill
€271.03M - Intangible assets
€14.64M - Long-term investments
€1.31M - Other non-current assets
€7.69M - Total non-current assets
€351.48M - Total assets
€704.09M - Accounts payable
€12.84M - Short-term debt
€1.20M - Other current liabilities
€24.25M - Total current liabilities
€50.97M - Long-term debt
€595.80M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€600.67M - Total liabilities
€651.64M - Common stock
€255.89K - Retained earnings
-€2.23B - Other equity
€227.74K - Total equity
€52.45M - Total liabilities and shareholders' equity
€704.09M
Company information
- Market capitalization
€330.19M - Employees
575 - Enterprise Value
€988.70M
Company ratios
- Gross margin
-
21.4% Much better than peer group: -160.5% - EBITDA margin
-
-295.7% Much better than peer group: -682.3% - EBIT margin
-
-422.1% Much better than peer group: -690.9% - EBT margin
-
-337.1% Much better than peer group: -902.8% - Net margin
-
-337.2% Much better than peer group: -898.6% - ROE
-
-856.0% Much worse than peer group: -27.6% - ROA
-
-63.8% Much worse than peer group: -40.6% - Asset turnover
-
18.9% Even with peer group: 14.6% - FCF margin
-
-97.6% Much better than peer group: -388.8% - FCF yield
-39.3% - Efficiency ratio
395.7% - Net sales per employee
-
€231.57K - Net income per employee
-
-€780.80K